PHP
STRO icon

Parkman Healthcare Partners’s Sutro Biopharma STRO Stock Holding History

Parkman Healthcare Partners’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-172,793
Closed -$3.18M – 103
2024
Q4 		$3.18M Buy
172,793
+1,180
+0.7% +$36K 0.42% 59
2024
Q3 		$5.94M Sell
171,613
-7,661
-4% -$300K 0.76% 46
2024
Q2 		$5.25M Buy
179,274
+269
+0.2% +$10.6K 0.7% 52
2024
Q1 		$10.1M Buy
179,005
+58,762
+49% +$2.6M 1.24% 32
2023
Q4 		$5.16M Buy
120,243
+2,026
+2% +$64.3K 0.73% 43
2023
Q3 		$4.1M Buy
118,217
+3,831
+3% +$167K 0.75% 38
2023
Q2 		$5.32M Buy
114,386
+4,382
+4% +$218K 0.92% 34
2023
Q1 		$5.08M Buy
110,004
+23,406
+27% +$1.49M 1.11% 36
2022
Q4 		$7M Buy
86,598
+17,864
+26% +$1.24M 1.86% 16
2022
Q3 		$3.81M Buy
68,734
+50,282
+273% +$2.98M 1.08% 29
2022
Q2 		$961K Sell
18,452
-1,533
-8% -$85.6K 0.35% 59
2022
Q1 		$1.64M Sell
19,985
-2,137
-10% -$203K 0.48% 55
2021
Q4 		$3.29M Buy
22,122
+5,783
+35% +$1.04M 0.73% 39
2021
Q3 		$3.09M Hold
16,339
– – 0.78% 39
2021
Q2 		$3.04M Sell
16,339
-3,931
-19% -$769K 0.66% 48
2021
Q1 		$4.61M Sell
20,270
-6,395
-24% -$1.52M 1.07% 32
2020
Q4 		$5.79M Buy
26,665
+5,665
+27% +$938K 1.48% 26
2020
Q3 		$2.11M Buy
+21,000
New +$1.98M 0.56% 57

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Parkman Healthcare Partners's STRO Position: Q1 2025 in Review

Parkman Healthcare Partners sold out of Sutro Biopharma (STRO) in Q1 2025, closing a stake of 172,793 shares — an estimated $3.18M sold.

Parkman Healthcare Partners first reported a position in STRO in Q3 2020 and held it in 18 quarters. The position peaked at $10.1M in Q1 2024. 112 funds tracked by Wall St. Rank hold STRO as of Q1 2025.

  • Parkman Healthcare Partners reported no remaining Sutro Biopharma position as of Q1 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 172,793 Sutro Biopharma shares in Q1 2025, an estimated $3.18M.
  • Parkman Healthcare Partners first reported a position in Sutro Biopharma in Q3 2020 and held it in 18 quarters.
  • Parkman Healthcare Partners's Sutro Biopharma position peaked at $10.1M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2025.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.